Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Mol Biochem Parasitol ; 145(1): 40-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16225937

ABSTRACT

Cyclic nucleotide phosphodiesterases constitute the only known mechanism to inactivate regulatory signals involving cAMP or cGMP. In our laboratory a cAMP-specific phosphodiesterase associated to the flagellar apparatus, named TcPDE1, was identified in Trypanosoma cruzi. By using the catalytic domain sequence of TcPDE1 to screen a Trypanosoma cruzi genomic data base, a novel T. cruzi phosphodiesterase sequence was found and characterized. TcPDE4 encodes a 924-amino acid protein and shows homology with the PDE4 vertebrate subfamily. The sequence shows three conserved domains, FYVE, phosphohydrolase and PDEaseI. The FYVE zinc-finger domain is characteristic of proteins recruited to phosphatidylinosytol 3-phosphate-containing membranes, whereas the two others are characteristic of phosphohydrolases and members of the cyclic nucleotide phosphodiesterases. Sequence analysis shows all characteristic domains present at the type-4 phosphodiesterases specific for cAMP. Moreover, TcPDE4 shows the inhibition profile characteristic for PDE4 subfamily, with an IC50 of 10.46 microM for rolipram and 1.3 microM for etazolate. TcPDE4 is able to complement a heat-shock-sensitive yeast mutant deficient in phosphodiesterase genes. The enzyme is specific for cAMP, Mg(2+)-dependent and its activity is not affected by cGMP or Ca(2+). The association of TcPDE4 with membranes was studied by subcellular fractionation of recombinant yeast and extraction in several conditions. Most of the enzyme remained associated to the membrane fraction after treatment with high salt concentration, detergent, or chaotropic agents. This support previous hypotheses that in this parasite cAMP phosphodiesterases, and consequently cAMP levels, are compartmentalized.


Subject(s)
3',5'-Cyclic-AMP Phosphodiesterases , Cell Membrane/enzymology , Trypanosoma cruzi/enzymology , 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , 3',5'-Cyclic-AMP Phosphodiesterases/genetics , 3',5'-Cyclic-AMP Phosphodiesterases/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Cyclic Nucleotide Phosphodiesterases, Type 4 , DNA, Protozoan/analysis , Etazolate/pharmacology , Kinetics , Molecular Sequence Data , Phosphodiesterase Inhibitors/pharmacology , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Rolipram/pharmacology , Sequence Alignment , Trypanosoma cruzi/genetics , Trypanosoma cruzi/growth & development
2.
Cell Signal ; 5(5): 615-21, 1993 Sep.
Article in English | MEDLINE | ID: mdl-7508732

ABSTRACT

The effect of 17 inhibitors of cyclic nucleotide phosphodiesterases (PDEs) was assayed on cAMP binding activity of Mucor rouxii protein kinase A (PKA), on PKA activity in the absence of cAMP and on free catalytic subunit (C) activity. Isobutylmethylxanthine (IBMX), SQ 20,009 and cilostamide, at 0.2 mM, behaved as partial agonists of cAMP since they inhibited binding of 0.15 microM [3H]cAMP to the regulatory subunit (R), stimulated slightly PKA activity in the absence of cAMP and did not modify C activity. Amrinone at 0.2 mM inhibited C activity competitively towards ATP. These four compounds displayed the same effects when assayed on eukaryotic protein kinase A types I (PKI) and II (PKII). The combined effect of IBMX and cAMP was analysed on Mucor PKA. Under dissociating conditions (+ 0.5 M NaCl) IBMX antagonized activation by low concentrations of cAMP, while in the absence of NaCl, IBMX potentiated the stimulating activity of cAMP.


Subject(s)
1-Methyl-3-isobutylxanthine/pharmacology , Cyclic AMP-Dependent Protein Kinases/metabolism , Phosphodiesterase Inhibitors/pharmacology , Animals , Cyclic AMP/metabolism , Etazolate/pharmacology , In Vitro Techniques , Mucor/enzymology , Myocardium/enzymology , Quinolones/pharmacology , Rats , Signal Transduction
3.
Arch Androl ; 26(2): 53-60, 1991.
Article in English | MEDLINE | ID: mdl-1852151

ABSTRACT

The release and phosphorylation/dephosphorylation mechanisms of human spermatozoa histone during nuclei in vitro decondensation by heparin was studied. Washed sperm cells were incubated in the presence of 32P and in the absence or presence of heparin. The results showed an increase in the incorporation of 32P of 20 times greater in the presence of heparin than in the absence of heparin (the control sample). In some cases the incorporation of 32P into histones was confirmed by its isolation. To validate these results a phosphorylation kinetic of isolated sperm histone, used as a substrate, was performed. The amount of 32P was not a linear function of time, and maximal phosphorylation was reached in 60 min. A measurement of 32P incorporated as a function of the amount of histone, shows a linear relationship of up to 50 micrograms of protein, with a rapid saturation thereafter with the incorporation of 220 nm and with a KD = 442 x 10(-6) mol/L. 32P incorporation, independent of exogenous cAMP, was related to alkaline pH but was totally dependent on temperature--with a maximum of 37 degrees C. The only histone released was histone H-3. Phosphorylation/dephosphorylation is involved during male pronuclei formation.


Subject(s)
Cell Nucleus/metabolism , Heparin/pharmacology , Histones/metabolism , Spermatozoa/ultrastructure , 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , Cell Nucleus/drug effects , Etazolate/pharmacology , Humans , Hydrogen-Ion Concentration , Kinetics , Male , Phosphorylation
SELECTION OF CITATIONS
SEARCH DETAIL